Breaking News

CVS whistleblower details drug pricing allegations; Verily co-founder on real-world data

  

 

Pharmalot Ed Silverman

STAT+: A 'veritable playground': CVS whistleblower details how patients were charged higher drug prices

By Ed Silverman

Gene J. Puskar/AP

The lawsuit describes a highly complicated plan designed to bolster CVS profits at the expense of consumers and American taxpayers.

Read More

STAT+: FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes

By Ed Silverman

Alex Brandon/AP

FTC puts drug industry on notice that paying rebates and fees to exclude competitors offering lower-cost drug alternatives can violate laws.

Read More

STAT+: A Roche treatment fails to slow cognitive decline in patients with inherited form of Alzheimer's disease

By Adam Feuerstein

AP

The trial tested an experimental antibody treatment in people born with an inherited form of early onset Alzheimer’s disease.

Read More

Romney accuses White House of 'patently false' information about Covid-19 funds

By Rachel Cohrs

Andrew Harnik/AP

Republican Sen. Mitt Romney accused the White House of providing "patently false" information about the urgency of new Covid-19 funding

Read More

Listen: Paul Offit on Covid vaccines for kids, plus: how the Fed affects biotech, & another Alzheimer's setback

By Damian Garde and Meg Tirrell and Adam Feuerstein

Longtime biotech investor Les Funtleyder joins us this week to explain why the recent interest rate hike is bad for biotech.

Read More

STAT+: Verily co-founder lays out vision for how real-world data can transform health care

By Jonathan Wosen

Jason Henry for STAT

STAT sat down with Jessica Mega, Verily’s co-founder and chief medical and scientific officer, to learn more about the issue.

Read More

Thursday, June 16, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments